单体,二元和三元酸盐之间的转化:olefins的NP类型的寡合化
Neil Burford1, T Stanley Cameron, Korey D Conroy
1Department of Chemistry, Dalhousie University, Halifax, Nova Scotia B3H 4J3, Canada. neil.burford@dal.ca
Journal of the American Chemical Society
|November 21, 2002
概括
大量的替代剂使伊米诺素和二酸晶体混合物的分离成为可能. 固态相互作用影响了平衡,并导致环膨胀反应形成三.
科学领域:
- 有机化学化学 有机化学
- 超分子化学 超分子化学
- 晶体学 晶体学是指结晶学.
背景情况:
- 伊米诺氨酸和二氨酸是-化合物的一类.
- 了解它们的聚合行为和反应性对于合成化学至关重要.
研究的目的:
- 为了分离和表征一个晶体混合物,伊米诺素1和二酸盐2.
- 研究固体相互作用在这些化合物的聚合和反应性中的作用.
主要方法:
- 单晶X射线衍射用于结构特征.
- 用于化合物识别的光谱方法 (NMR,IR).
- 化学反应的监测.
主要成果:
- 成功地分离并描述了一种含有大量R组 (Mes*,X = OTf) 的伊米诺1和二酸2结晶混合物.
- 证据显示,单体/二元平衡受固体阻碍的影响.
- 对随后的环膨胀反应产生三酸盐3 (R=Dipp,X=Cl) 的观察.
结论:
- 大量替代品的绝缘效应是控制伊米诺素和二酸盐的隔离和聚合状态的关键.
- 观察到的环膨胀反应凸显了这些-系统的动态性质和潜在转变.
相关概念视频
Preparation of Epoxides
7.7K
Overview
Epoxides result from alkene oxidation, which can be achieved by a) air, b) peroxy acids, c) hypochlorous acids, and d) halohydrin cyclization.
Epoxidation with Peroxy Acids
Epoxidation of alkenes via oxidation with peroxy acids involves the conversion of a carbon–carbon double bond to an epoxide using the oxidizing agent meta-chloroperoxybenzoic acid, commonly known as MCPBA. Since the O–O bond of peroxy acids is very weak, the addition of electrophilic oxygen of peroxy...
Epoxides result from alkene oxidation, which can be achieved by a) air, b) peroxy acids, c) hypochlorous acids, and d) halohydrin cyclization.
Epoxidation with Peroxy Acids
Epoxidation of alkenes via oxidation with peroxy acids involves the conversion of a carbon–carbon double bond to an epoxide using the oxidizing agent meta-chloroperoxybenzoic acid, commonly known as MCPBA. Since the O–O bond of peroxy acids is very weak, the addition of electrophilic oxygen of peroxy...
7.7K
Characteristics and Nomenclature of Homopolymers
3.1K
Polymers that are made up of identical monomer units are called homopolymers. Only one repeating unit is involved in the construction of the homopolymer structure. For example, as depicted in Figure 1, polypropylene is a homopolymer constituted of propylene monomers. Here, the only repeating unit in the polymer chain is propylene.
3.1K
Olefin Metathesis Polymerization: Overview
1.8K
Recently, the development of olefin metathesis polymerization advanced the field of polymer synthesis. Simply put, the reorganization of substituents on their double bonds between two olefins in the presence of a catalyst is known as the olefin metathesis reaction. The use of metathesis reaction for polymer synthesis is called olefin metathesis polymerization.
Ruthenium-based Grubbs catalyst is the most commonly used catalyst for olefin metathesis polymerization. Grubbs catalyst consists of a...
Ruthenium-based Grubbs catalyst is the most commonly used catalyst for olefin metathesis polymerization. Grubbs catalyst consists of a...
1.8K
Olefin Metathesis Polymerization: Ring-Opening Metathesis Polymerization (ROMP)
2.3K
Ring-opening metathesis polymerization or ROMP involves strained cycloalkenes as starting materials. The mechanism of ROMP proceeds by reacting cycloalkene with Grubbs catalyst to give metallacyclobutane intermediate which undergoes a ring-opening reaction to form new carbene. The new carbene reacts with another molecule of cycloalkene. Repetition of these steps leads to the formation of an unsaturated open-chain polymer product. All these steps are reversible, however, relieving the ring...
2.3K
Olefin Metathesis Polymerization: Acyclic Diene Metathesis (ADMET)
1.4K
Acyclic diene metathesis polymerization or ADMET polymerization involves cross-metathesis of terminal dienes, such as 1,8-nonadiene, to give linear unsaturated polymer and ethylene. As ADMET is a reversible process, the formed ethylene gas must be removed from the reaction mixture to complete the polymerization process.
Similar to cross-metathesis, ADMET also involves the formation of metallacyclobutane intermediate by [2+2] cycloaddition of one of the double bonds of a terminal diene with...
Similar to cross-metathesis, ADMET also involves the formation of metallacyclobutane intermediate by [2+2] cycloaddition of one of the double bonds of a terminal diene with...
1.4K
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
228
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
228


